Fas receptor (CD95)-Mediated apoptosis in leukemic cells

Leukemia and Lymphoma

Volumn 25, Issue 1-2, 1997, Pages 9-21

  Komada, Yoshihiro ^a   Sakurai, Minoru ^a  

^a MIE UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Acute myelogenous leukemia; Apoptosis; CD95; Cell cycle; Fas ligand; Fas receptor

Indexed keywords

CYTOKINE; FAS ANTIGEN; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; GROWTH PROMOTOR; INTERLEUKIN 2; INTERLEUKIN 3; MESSENGER RNA;

ACUTE GRANULOCYTIC LEUKEMIA; ANTIGEN BINDING; APOPTOSIS; CELL CYCLE; CELL DEATH; CROSS LINKING; DNA SYNTHESIS; HUMAN; HUMAN CELL; IMMUNOTHERAPY; LEUKEMIA CELL; PRIORITY JOURNAL; REVIEW; T LYMPHOCYTE;

EID: 0030945057     PISSN: 10428194     EISSN: None     Source Type: Journal    
DOI: 10.3109/10428199709042492     Document Type: Review

References (65)

1. Nagata, S and Golstein, P. (1995). The Fas death factor. Science, 267, 1449-1456.
2. Cleveland, J. L. and Ihle, J. N. (1995) Contenders in FasL/TNF death signaling. Cell, 81, 479-482.
3. Itoh, N., Yonehara, S., Ishil, A., Yonehara, M., Mizushima, S., Sameshima, M., Hase, A., Seto, Y. and Nagata, S. (1991). The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis Cell. 66, 233-243.
4. Oehm, A., Behrmann, I., Falk, W., Pawlita, M., Maier, G., Klas, C., Li-Weber, M., Richards, S., Dhein, J., Trauth, B. C., Ponstingl, H. and Krammer, P. H. (1992) Purification and molecular cloning of the APO-1 cell surface antigen, a member of the tumor necrosis factor/nerve growth factor receptor family. J. Biol. Chem., 267, 10709-10715.
5. Yonehara, S., Ishii, A. and Yonehara, M. (1989). A cell-killing monoclonal antibody (anti-Fas) to a cell surface antigen co-downregulated with the receptor of tumor necrosis factor. J. Exp. Med., 169, 1747-1756.
6. Watanabe-Fukunaga, R., Brannan, C. I., Itoh, N., Yonehara, S., Copeland, N G., Jenkins, N. A. and Nagata, S. (1992). The cDNA structure, expression, and chromosomal assignment of the mouse Fas antigen. J. Immunol., 148, 1274-1279.
7. Ogasawara, J. Watanabe-Fukunaga, R., Adachi, M., Matsuzawa, A., Kasugai, T., Kitamura, Y., Itoh, N., Suda, T. and Nagata, S. (1993). Lethal effect of the anti-Fas antibody in mice. Nature, 364, 806-809.
8. Suda, T., Takahashi, T., Golstein, P. and Nagata, S. (1993). Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family. Cell, 75, 1169-1178.
9. Takahashi, T., Tanaka, M., Inazawa, J., Abe, T., Suda, T and Nagata, S. (1994) Human Fas ligand: gene structure, chromosomal location and species specificity. Int. Immunol., 6, 1567-1574.
10. Suda, T., Okazaki, T., Naito, Y., Yokota, T., Arai, N., Ozaki, S., Nakao, K. and Nagata, S. (1995). Expression of the Fas ligand in cells of T cell lineage. J. Immunol., 154, 3806-3813.
11. Bellgrau, D., Gold, D., Selawry, H., Moore, J., Franzusoff, A and Duke, R. C (1995). A role of CD95 ligand in preventing graft rejection. Nature, 377, 630-632.
12. Watanabe-Fukunaga, R., Brannan, C. I., Copeland, N. G., Jenkins, N. A and Nagata, S. (1992). Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis Nature, 356, 314-317
13. + thymocytes and activated mature lymphocytes in normal mice but not in the lupus-prone strain. MRL lpr/lpr. Proc. Natl. Acad. Sci. USA, 90, 10340-10344
14. Adachi, M., Watanabe-Fukunaga, R. and Nagata, S. (1993). Aberrant transcription caused by the insertion of an early transposable element in an intron of the Fas antigen gene of lpr mice. Proc Natl. Acad. Sci USA, 90, 1756-1760.
15. Takahashi, T., Tanaka, M., Brannan, C. I., Jenkins, N. A., Copelandm, N. G., Suda, T. and Nagata, S. (1994). Generalized lymphoproliferative disease in mice, caused by a point mutation in the Fas ligand. Cell, 76, 969-976.
16. Owen-Schaub, L B., Yonehara, S., Crump, W. L. and Grimm, E. A (1992). DNA fragmentation and cell death is selectively triggered in activated human T lymphocytes by Fas antigen engagement. Cell. Immunol., 140, 197-205.
17. Lowin, B., Hahne, M., Mattmann, C. and Tschopp, J. (1994). Cytolytic T-cell cytotoxicity is mediated through perform and Fas lytic pathways. Nature, 370, 650-652.
18. Hanabuchi, S., Koyanagi, M., Kawasaki, A., Shinohara, I., Matsuzawa, A., Nishimura, Y., Kobayashi, Y., Yonehara, S., Yagita, H. and Okumura, K. (1994). Fas and its ligand in a general mechanism of T-cell-mediated cytotoxicity. Proc. Natl. Acad. Sci. USA, 91, 4930-4934.
19. Kagi, D., Vignaux, F., Ledermann, B., Burk, K., Depraetere, V., Nagata, S., Hengartner, H. and Golstein, P. (1994). Fas and perforin pathway as major mechanisms of T cell-mediated cytotoxicity. Science, 265, 528-530.
20. Vignaux, F., Vivier, E., Malissen, B., Detraetere, V., Nagata, S. and Golstein, P. (1995). TCR/CD3 coupling to Fas-based cytotoxicity. J. Exp. Med., 181, 781-786.
21. Miyawaki, T., Uehara, T., Nibu, R., Tsuji, T., Yachie, A., Yonehara, S. and Taniguchi, N. (1992). Differential expression of apoptosis-related Fas antigen on lymphocyte subpopulations in human peripheral blood. J. Immunol., 149, 3753-3758.
22. Druilhe, A., Cai, Z., Haile, S., Chouaib, S. and Pretolani, M. (1996). Fas-mediated apoptosis in cultured human eosmophiis. Blood, 87, 2822-2830.
23. Falk, M. H., Trauth, B. C., Debatin, K.-M., Klas, C., Gregory, C. D., Rickinson, A. B., Calender, A., Lenoir, G. M., Ellwart, J. W., Krammer, P. H. and Bornkamm, G. W. (1992). Expression of the APO-1 antigen in Burkitt's lymphoma cell lines correlates with a shift towards a lymphoblastoid phenotype Blood, 79, 3300-3306.
24. Moller, P., Henne, C., Leithauser, F., Eichlmann, A., Schmidt, A., Bruderlein, S., Dhein, J. and Krammer, P. H. (1993). Coregulation of the APO-1 antigen with intercellular adhesion molecule-1 (CD54) in tonsillar B cells and coordinate expression in follicular center B cells and in follicle center and mediastinal B-cell lymphomas. Blood, 81, 2067-2075.
25. Shima, Y., Nishimoto, N., Ogata, A., Fujii, Y., Yoshizaki, K. and Kishimoto, T. (1995). Myeloma cells express Fas antigen/APO-1 (CD95) but only some are sensitive to anti-Fas antibody resulting in apoptosis. Blood, 85, 757-764
26. Debatin, K.-M., Goldman, C K., Waldmann, T. A. and Krammer, P. H (1993). APO-1-induced apoptosis of leukemia cells from patients with adult T-cell leukemia. Blood, 81, 2972-2977.
27. Nishimura, Y., Ishii, A. and Yonehara, S. (1995). Expression and function of apoptosis antigen Fas on T lymphocytes in periphery and thymus. In Leukocyte Typing V., edited by S. F. Schlossman, L. Boumsell, W. Gilks, J. M. Harlan, T. Kishimoto, C. Morimoto, J. Ritz, S. Shaw, R. Silverstein, T. Springer, T. F. Tedder and R. F. Todd, (Tokyo: Oxford University Press.) pp. 1144-1148.
28. + human marrow cells in induced by Interferon γ and tumor necrosis factor α and potentiates cytokine-mediated hematopoietic suppression in vitro. Blood, 85, 3183-3190.
29. Komada, Y., Zhou, Y.-W., Zhang, X.-L., Xue, H.-L., Sakai, H., Tanaka, S., Sakatoku, H. and Sakurai, M. (1995). Fas receptor (CD95)-mediated apoptosis is induced in leukemic cells entering G1B compartment of the cell cycle. Blood, 86, 3848-3860.
30. Migliorati, G., Nicoletti, I., Pagliacci, M. C., D'Adamio, L. and Riccardi, C. (1993). Interleukin-4 protects double-negative and CD4 single-positive thymocytes from dexamethasone-induced apoptosis. Blood, 81, 1352-1358.
31. Komada, Y., Zhang, X. L., Zhou, Y. W., Tanaka, S., Higashigawa, M., Ido, M. and Sakurat, M. (1994). Apoptotic cell death induced by anti-IgM antibody and phorbol esters is inhibited by interleukin-4 in human B lymphoma cell line MBC-1. Cell. Immunol., 159, 280-293.
32. Sato, T., Ine, S., Kitada, S. and Reed, J. C. (1995). FAP-1: a protein tyrosine phosphatase that associates with Fas. Science, 268, 411-415.
33. Chinnaiyan, A. M., O'Rourke, K., Tewari, M. and Dixit, V. M. (1995). FADD, a novel death domain-containing protein, interacts with the death domain of Fas and initiates apoptosis. Cell, 81, 505-512.
34. Stanger, B. Z. Leder, P., Lee, T.-H., Kim, E. and Seed, B. (1995). RIP: a novel protein containing a death domain that interacts with Fas/APO-1 (CD95) in yeast and causes cell death. Cell, 81, 513-523.
35. Cifone, M. G., De Maria, R., Roncaioli, P., Rippo, M. R., Lanier, L. L., Santoni, A. and Testi, R. (1994). Apoptotic signaling through CD95 (Fas/Apo-1) activates an acidic sphingomyelinase. J. Exp. Med., 180, 1547-1552.
36. Jarvis, W. D., Kolesnick, R. N., Fomari, F. A., Traylor, R. S., Gewirtz, D. A. and Grant, S. (1994). Induction of apoptotic DNA damage and cell death by activation of the sphingomyelin pathway. Proc. Natl. Acad. Sci. USA, 91, 73-77.
37. Enari, M., Hug, H and Nagata, S. (1995). Involvement of an ICE-like protease in Fas-mediated apoptosis. Nature, 375, 78-81.
38. Los, M., Van de Craen, M., Penning, L. C., Schenk, H., Westendorp, M., Baeuerle, P. A., Droge, W., Krammer, P. H., Fiers, W. and Schulze-Osthoff, K. (1995). Requirement of an ICE/CED-3 protease for Fas/APO-1-mediated apoptosis. Nature, 375, 81-83.
39. Enari, M., Talanian, R. V., Wong, W W. and Nagata, S. (1996). Sequential activation of ICE-like and CPP32-like proteases during Fas-mediated apoptosis. Nature, 380, 723-726.
40. Cocombel, M., Olsson, C. A., Ng, P.-Y. and Buttyan, R. (1992). Hormone-regulated apoptosis results from reentry of differentiated prostate cells onto a defective cell cycle. Cancer Res., 52, 4313-4319.
41. Scott, D., Livnat, D., Pennell, C. A. and Keng, P. (1986). Lymphoma models for B cell activation and tolerance III. cell cycle dependence for negative signaling of WEHI-231 B lymphoma cells by anti-μ. J. Exp. Med., 164, 156-164.
42. Evan, G. I., Wyllie, A. H., Gilbert, C. S., Littlewood, T. D., Land, H., Brooks, M., Waters, C. M., Penn, L. Z. and Hancock, D. C. (1992). Induction of apoptosis in fibroblasts by c-myc protein. Cell, 69, 119-128.
43. Meikrantz, W., Gisselbrecht, S., Tam, S W. and Schlegel, R. (1994). Activation of cyclin A-dependent protein kinases during apoptosis Proc. Natl. Acad. Sci USA, 91, 3754-3758.
44. Ishigami, T., Kim, K.-M., Horiguchi, Y., Higaki, Y., Hata, D., Heike, T., Katamura, K., Mayumi, M. and Mikawa, H. (1992). Anti-IgM antibody-induced cell death in a human B lymphoma cell line, B104, represents a novel programmed cell death. J. Immunol., 148, 360-368.
45. Belizario, J. E. and Dinarello, C. A. (1991). Interleukin 1, interleukin 6, tumor necrosis factor, and transforming growth factor β increase cell resistance to tumor necrosis factor cytotoxicity by growth arrest in the G1 phase of the cell cycle. Cancer Res., 51, 2379-2385.
46. Chen, M.-J., Holskin, B., Strickler, J., Gomiak, J., Clark, M. A., Johnson, P. J., Mitcho, M. and Shalloway, D. (1987). Induction by E1A oncogene expression of cellular susceptibility to lysis by TNF. Nature, 330, 581-583.
47. Bissonnette, R. P., Echeverri, F., Mahboubi, A. and Green, D. R. (1992). Apoptotic cell death induced by c-myc is inhibited by bcl-2. Nature, 359, 552-556.
48. Lowe, S. W., Ruley, H. E., Jacks, T. and Housman, D. E. (1993). p53-dependent apoptosis modulates the cytotoxicity of anticancer agents. Cell, 74, 957-967.
49. Komada, Y., Zhou, Y.-W., Zhang, S.-L., Azuma, E. and Sakurai, M. (1993). Role in growth regulation of cytokines and cytokine receptors in acute lymphoblastic leukaemia expressing myeloid markers. Brit. J. Haematol., 84, 408-415.
50. Delwel, R., Salem, M., Pellens, C., Dorssers, L., Wagemaker, G., Clark, S. and Lowenberg, B. (1988). Growth regulation of human acute myeloid leukemia: Effects of five recombinant hematopoietic factors in a serum-free culture system. Blood, 72, 1944-1949.
51. 2/M-phase fraction in human myeloid leukemia cells. Exp. Hematol., 21, 1597-1604.
52. Kinoshita, T., Yokota, T., Arai, K. and Miyajima, A. (1995). Suppression of apoptotic death in hematopoietic cells by signaling through the IL-3/GM-CSF receptors. EMBO J., 14, 266-275.
53. Shapiro, H. M. (1981). Flow cytometric estimation of DNA and RNA content in intact cells stained with Hoechst 33342 and pyronin Y. Cytometry, 2, 143-150.
54. Rabinovitch, P. S., Torres, R. M. and Engel, D. (1986). Simultaneous cell cycle analysis and two-color surface immunofluorescence using 7-amino-actinomycin D and single laser excitation: applications to study of cell activation and the cell cycle of murine Ly-1 B cells. J. Immunol., 136, 2769-2775.
55. Toba, K., Winton, E. F and Bray, R. A. (1992). Improved staining method for the simultaneous flow cytofluorometric analysis of DNA content, S-phase fraction, and surface phenotype using single laser instrumentation. Cytometry, 13, 60-67.
56. Lowin, B., Mattman, C., Hahne, M. and Tschopp, J. (1996). Comparison of Fas (APO-1/CD95)- and perform-mediated cytotoxicity in primary T lymphocytes. Int. Immunol., 8, 57-63.
57. Alderson, M. R., Tough, T. W., David-Smith, T., Braddy, S., Falk, B., Schooley, K. A., Goodwin, R. G., Smith, C. A., Ramsdell, F. and Lynch, D. H. (1995). Fas ligand mediates activation-induced cell death in human T lymphocytes. J. Exp. Med., 181, 71-77.
58. Tan, P. H., Liu, Y., Santos, E. B. and Sandmaier, B. M. (1995). Mechanisms of enhancement of natural killer activity by an antibody to CD44: Increase in conjugate formation and release of tumor necrosis factor α Cell. Immunol., 164, 255-264.
59. + killer cells. Blood, 86, 3493-3499.
60. Kagi, D., Ledermann, B., Burki, K., Seiler, P., Odermatt, B., Olsen, K. J., Podack, E. R., Zinkernagel, R. M. and Hengartner, H. (1994). Cytotoxicity mediated by T cells and natural killer cells is greatly impaired in perforin-deficient mice. Nature, 369, 31-37.
61. Heusel, J., Wesselschmidt, R. L., Shresta, S., Russell, J. H. and Ley, T. J. (1994). Cytotoxic lymphocytes require Granzyme B for the rapid induction of DNA fragmentation and apoptosis in allogeneic target cells. Cell 76, 977-987.
62. + T cells in graft-versus-leukemia activity and engraftment after allogeneic bone marrow transplantation. Transplantation, 60, 355-361.
63. - cytotoxic T-cell clones specific for leukemic blasts in children with acute leukemia. Cancer Res., 55, 3835-3839
64. Slavin, S., Naparstek, E., Nagler, A., Ackerstein, A., Kapelushnik, J. and Or, R. (1995). Allogeneic cell therapy for relapsed leukemia after bone marrow transplantation with donor peripheral blood lymphocytes Exp. Hematol., 23, 1553-1562.
65. Naparstek, E., Or, R., Nagler, A., Cividalli, G., Engelhard, D., Aker, M., Gimon, Z., Manny, N., Sacks, T., Tochner, Z., Weiss, L., Samuel, S., Brautbar, C., Hale, G., Waldmann, H., Steinberg, S. M. and Slavin, S. (1995). T-cell-depleted allogeneic bone marrow transplantation for acute leukaemia using Campath-1 antibody and post-transplant administration of donor's peripheral blood lymphocytes for prevention of relapse. Brit. J. Haematol., 89, 506-515.